LIFECORE BIOMEDICAL, INC. Research and Development Expense
LIFECORE BIOMEDICAL, INC. (LFCR) reported Research and Development Expense of $1.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. research and development expense for the quarter ending 2026-06-30 was $1.54M.
- LIFECORE BIOMEDICAL, INC. research and development expense for the quarter ending 2026-03-31 was $1.22M.
- LIFECORE BIOMEDICAL, INC. research and development expense for the quarter ending 2025-09-30 was $1.96M.
- LIFECORE BIOMEDICAL, INC. research and development expense for the quarter ending 2025-05-25 was $2.10M, a 2.68% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. research and development expense for fiscal 2025 was $8.26M, a 3.70% decline from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. research and development expense for fiscal 2024 was $8.57M, a 1.84% decline from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. research and development expense for fiscal 2023 was $8.74M, a 11.44% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. research and development expense for fiscal 2022 was $7.84M, a 17.28% increase from fiscal 2021.
| Period end | Research and Development Expense 1 month | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 7 month | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.54M 10-Q · filed 2026-08-05 | $2.75M 10-Q · filed 2026-08-05 | ||||||||
| 2026-03-31 | $1.22M 10-Q · filed 2026-05-06 | |||||||||
| 2025-12-31 | $4.96M 10-KT · filed 2026-03-16 | |||||||||
| 2025-09-30 | $1.96M 10-Q · filed 2025-11-06 | |||||||||
| 2025-06-30 | $705.00K 10-KT · filed 2026-03-16 | |||||||||
| 2025-05-25 | $2.10M 10-Q · filed 2026-08-05 | $4.15M 10-Q · filed 2026-08-05 | $6.07M derived: sum of 3 quarters · filed 2026-08-05 | $8.26M 10-KT · filed 2026-03-16 | ||||||
| 2025-02-23 | $2.04M 10-Q · filed 2026-05-06 | $3.97M derived: sum of 2 quarters · filed 2026-05-06 | $6.16M 10-Q · filed 2025-04-03 | $8.32M derived: sum of 4 quarters · filed 2026-05-06 | ||||||
| 2024-12-31 | $4.72M 10-KT · filed 2026-03-16 | |||||||||
| 2024-11-24 | $1.92M 10-Q · filed 2025-01-02 | $4.11M 10-Q · filed 2025-01-02 | $6.27M derived: sum of 3 quarters · filed 2026-03-16 | $8.44M derived: sum of 4 quarters · filed 2026-03-16 | ||||||
| 2024-08-25 | $2.19M 10-Q · filed 2025-11-06 | $4.35M derived: sum of 2 quarters · filed 2026-03-16 | $6.52M derived: sum of 3 quarters · filed 2026-03-16 | $8.62M derived: sum of 4 quarters · filed 2026-03-16 | ||||||
| 2024-05-26 | $2.16M derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16 | $4.33M derived: sum of 2 quarters · filed 2026-03-16 | $6.43M derived: sum of 3 quarters · filed 2026-03-16 | $8.57M 10-KT · filed 2026-03-16 | ||||||
| 2024-02-25 | $2.17M 10-Q · filed 2025-04-03 | $4.27M derived: sum of 2 quarters · filed 2025-04-03 | $6.41M 10-Q · filed 2025-04-03 | $8.53M derived: sum of 4 quarters · filed 2025-04-03 | ||||||
| 2023-11-26 | $2.10M 10-Q · filed 2025-01-02 | $4.24M 10-Q · filed 2025-01-02 | $6.36M derived: sum of 3 quarters · filed 2025-01-02 | $8.59M derived: sum of 4 quarters · filed 2025-01-02 | ||||||
| 2023-08-27 | $2.15M 10-Q · filed 2024-10-04 | $4.26M derived: sum of 2 quarters · filed 2024-10-04 | $6.50M derived: sum of 3 quarters · filed 2024-10-04 | $8.67M derived: sum of 4 quarters · filed 2024-10-04 | ||||||
| 2023-05-28 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $4.35M derived: sum of 2 quarters · filed 2024-08-26 | $6.53M derived: sum of 3 quarters · filed 2024-08-26 | $8.74M 10-K · filed 2024-08-26 | ||||||
| 2023-02-26 | $2.23M 10-Q · filed 2024-08-09 | $1.96M 10-Q · filed 2023-06-02 | $4.41M derived: sum of 2 quarters · filed 2024-08-09 | $6.62M 10-Q · filed 2024-08-09 | $6.13M 10-Q · filed 2023-06-02 | $8.74M derived: sum of 4 quarters · filed 2024-08-26 | ||||
| 2022-11-27 | $2.18M 10-Q · filed 2024-08-09 | $2.12M 10-Q · filed 2023-03-16 | $4.39M 10-Q · filed 2024-08-09 | $4.17M 10-Q · filed 2023-03-16 | $6.50M derived: sum of 3 quarters · filed 2024-08-26 | $8.76M derived: sum of 4 quarters · filed 2024-08-26 | ||||
| 2022-08-28 | $2.21M 10-Q · filed 2024-08-09 | $2.05M 10-Q · filed 2022-10-07 | $4.33M derived: sum of 2 quarters · filed 2024-08-26 | $6.58M derived: sum of 3 quarters · filed 2024-08-26 | $8.26M derived: sum of 4 quarters · filed 2024-08-26 | |||||
| 2022-05-29 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $4.37M derived: sum of 2 quarters · filed 2024-08-26 | $6.05M derived: sum of 3 quarters · filed 2024-08-26 | $7.84M 10-K · filed 2024-08-26 | $7.84M 10-K · filed 2022-09-14 | |||||
| 2022-02-27 | $2.25M 10-K · filed 2024-03-20 | $2.06M 10-Q · filed 2022-04-07 | $3.93M derived: sum of 2 quarters · filed 2024-03-20 | $5.72M 10-Q · filed 2023-06-02 | $5.79M 10-Q · filed 2022-04-07 | $6.78M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-11-28 | $1.68M 10-K · filed 2024-03-20 | $2.72M 10-Q · filed 2022-01-07 | $3.73M 10-Q · filed 2023-03-16 | $5.54M 10-Q · filed 2022-01-07 | $4.53M derived: sum of 3 quarters · filed 2024-03-20 | $6.17M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-08-29 | $1.69M 10-K · filed 2024-03-20 | $2.83M 10-Q · filed 2021-10-05 | $2.85M derived: sum of 2 quarters · filed 2024-03-20 | $4.49M derived: sum of 3 quarters · filed 2024-03-20 | $6.08M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2021-05-30 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $2.80M derived: sum of 2 quarters · filed 2024-03-20 | $4.39M derived: sum of 3 quarters · filed 2024-03-20 | $6.68M 10-K · filed 2024-03-20 | $10.22M 10-K · filed 2021-07-29 | |||||
| 2021-02-28 | $1.64M 10-K · filed 2024-03-20 | $2.56M 10-Q · filed 2021-04-08 | $3.23M derived: sum of 2 quarters · filed 2024-03-20 | $5.52M 10-Q · filed 2022-04-07 | $7.64M 10-Q · filed 2021-04-08 | $4.16M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2020-11-29 | $1.59M 10-K · filed 2024-03-20 | $2.57M 10-Q · filed 2021-01-07 | $5.08M 10-Q · filed 2022-01-07 | $2.52M derived: sum of 3 quarters · filed 2024-03-20 | $5.27M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2020-08-30 | $1.74M 10-K · filed 2024-03-20 | $2.51M 10-Q · filed 2020-10-07 | $931.00K derived: sum of 2 quarters · filed 2024-03-20 | $3.68M derived: sum of 3 quarters · filed 2024-03-20 | $6.50M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2020-05-31 | -$808.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $1.94M derived: sum of 2 quarters · filed 2023-03-16 | $4.76M derived: sum of 3 quarters · filed 2023-03-16 | $7.58M 10-K/A · filed 2023-03-16 | $11.10M 10-K · filed 2020-08-14 | |||||
| 2020-02-23 | $2.75M 10-Q · filed 2021-04-08 | $5.57M derived: sum of 2 quarters · filed 2021-04-08 | $8.39M 10-Q · filed 2021-04-08 | $11.85M derived: sum of 4 quarters · filed 2021-07-29 | ||||||
| 2019-11-24 | $2.82M 10-Q · filed 2021-01-07 | $5.64M 10-Q · filed 2021-01-07 | $9.10M derived: sum of 3 quarters · filed 2021-07-29 | $11.84M derived: sum of 4 quarters · filed 2021-07-29 | ||||||
| 2019-08-25 | $2.82M 10-Q · filed 2020-10-07 | $6.28M derived: sum of 2 quarters · filed 2021-07-29 | $9.02M derived: sum of 3 quarters · filed 2021-07-29 | $11.50M derived: sum of 4 quarters · filed 2021-07-29 | ||||||
| 2019-05-26 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $6.20M derived: sum of 2 quarters · filed 2021-07-29 | $8.68M derived: sum of 3 quarters · filed 2021-07-29 | $11.47M 10-K · filed 2021-07-29 | ||||||
| 2019-02-24 | $2.74M 10-Q · filed 2020-04-03 | $2.74M 10-Q · filed 2019-04-04 | $5.21M derived: sum of 2 quarters · filed 2020-04-03 | $8.01M 10-Q · filed 2020-04-03 | $8.11M 10-Q · filed 2019-04-04 | $11.60M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2018-11-25 | $2.48M 10-Q · filed 2020-01-02 | $2.53M 10-Q · filed 2019-01-07 | $5.27M 10-Q · filed 2020-01-02 | $5.37M 10-Q · filed 2019-01-07 | $8.86M derived: sum of 3 quarters · filed 2020-08-14 | $11.97M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2018-08-26 | $2.79M 10-Q · filed 2019-10-03 | $2.83M 10-Q · filed 2018-10-05 | $6.39M derived: sum of 2 quarters · filed 2020-08-14 | $9.50M derived: sum of 3 quarters · filed 2020-08-14 | $12.87M derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-05-27 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $6.71M derived: sum of 2 quarters · filed 2020-08-14 | $10.08M derived: sum of 3 quarters · filed 2020-08-14 | $12.80M 10-K · filed 2020-08-14 | ||||||
| 2018-02-25 | $3.11M 10-Q · filed 2019-04-04 | $6.49M derived: sum of 2 quarters · filed 2019-04-04 | $9.20M 10-Q · filed 2019-04-04 | $12.76M derived: sum of 4 quarters · filed 2019-08-01 | ||||||
| 2017-11-26 | $3.37M 10-Q · filed 2019-01-07 | $6.09M 10-Q · filed 2019-01-07 | $9.65M derived: sum of 3 quarters · filed 2019-08-01 | $11.66M derived: sum of 4 quarters · filed 2019-08-01 | ||||||
| 2017-08-27 | $2.72M 10-Q · filed 2018-10-05 | $6.28M derived: sum of 2 quarters · filed 2019-08-01 | $8.29M derived: sum of 3 quarters · filed 2019-08-01 | $10.25M derived: sum of 4 quarters · filed 2019-08-01 | ||||||
| 2017-05-28 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | $5.57M derived: sum of 2 quarters · filed 2019-08-01 | $7.54M derived: sum of 3 quarters · filed 2019-08-01 | $9.47M 10-K · filed 2019-08-01 | ||||||
| 2017-02-26 | $2.01M 10-Q · filed 2018-04-05 | $3.98M derived: sum of 2 quarters · filed 2018-04-05 | $5.92M 10-Q · filed 2018-04-05 | $7.73M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2016-11-27 | $1.97M 10-Q · filed 2018-01-05 | $3.90M 10-Q · filed 2018-01-05 | $5.72M derived: sum of 3 quarters · filed 2018-08-09 | $7.61M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2016-08-28 | $1.94M 10-Q · filed 2017-09-28 | $3.75M derived: sum of 2 quarters · filed 2018-08-09 | $5.65M derived: sum of 3 quarters · filed 2018-08-09 | $7.29M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2016-05-29 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | $3.71M derived: sum of 2 quarters · filed 2018-08-09 | $5.35M derived: sum of 3 quarters · filed 2018-08-09 | $7.23M 10-K · filed 2018-08-09 | ||||||
| 2016-02-28 | $1.90M 10-Q · filed 2017-04-07 | $3.54M derived: sum of 2 quarters · filed 2017-04-07 | $5.41M 10-Q · filed 2017-04-07 | $7.03M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2015-11-29 | $1.64M 10-Q · filed 2017-01-05 | $3.52M 10-Q · filed 2017-01-05 | $5.13M derived: sum of 3 quarters · filed 2018-03-15 | $6.89M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2015-08-30 | $1.88M 10-Q · filed 2016-09-29 | $3.49M derived: sum of 2 quarters · filed 2018-03-15 | $5.24M derived: sum of 3 quarters · filed 2018-03-15 | $7.07M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2015-05-31 | $1.61M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | $3.37M derived: sum of 2 quarters · filed 2018-03-15 | $5.19M derived: sum of 3 quarters · filed 2018-03-15 | $6.99M 10-K/A · filed 2018-03-15 | ||||||
| 2015-03-01 | $1.75M 10-Q · filed 2016-03-30 | $3.58M derived: sum of 2 quarters · filed 2016-03-30 | $5.38M 10-Q · filed 2016-03-30 | $7.01M derived: sum of 4 quarters · filed 2016-08-01 | ||||||
| 2014-11-30 | $1.82M 10-Q · filed 2016-01-07 | $3.62M 10-Q · filed 2016-01-07 | $5.26M derived: sum of 3 quarters · filed 2016-08-01 | $6.98M derived: sum of 4 quarters · filed 2016-08-01 | ||||||
| 2014-08-31 | $1.79M 10-Q · filed 2015-10-01 | $3.43M derived: sum of 2 quarters · filed 2016-08-01 | $5.15M derived: sum of 3 quarters · filed 2016-08-01 | $7.07M derived: sum of 4 quarters · filed 2016-08-01 | ||||||
| 2014-05-25 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $3.36M derived: sum of 2 quarters · filed 2016-08-01 | $5.28M derived: sum of 3 quarters · filed 2016-08-01 | $7.20M 10-K · filed 2016-08-01 | ||||||
| 2014-02-23 | $1.72M 10-Q · filed 2015-04-02 | $3.64M derived: sum of 2 quarters · filed 2015-04-02 | $5.57M 10-Q · filed 2015-04-02 | $8.22M derived: sum of 4 quarters · filed 2015-07-31 | ||||||
| 2013-11-24 | $1.92M 10-Q · filed 2015-01-09 | $3.85M 10-Q · filed 2015-01-09 | $6.50M derived: sum of 3 quarters · filed 2015-07-31 | $8.82M derived: sum of 4 quarters · filed 2015-07-31 | ||||||
| 2013-08-25 | $1.93M 10-Q · filed 2014-10-08 | $4.58M derived: sum of 2 quarters · filed 2015-07-31 | $6.90M derived: sum of 3 quarters · filed 2015-07-31 | $9.02M derived: sum of 4 quarters · filed 2015-07-31 | ||||||
| 2013-05-26 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $4.98M derived: sum of 2 quarters · filed 2015-07-31 | $7.09M derived: sum of 3 quarters · filed 2015-07-31 | $9.29M 10-K · filed 2015-07-31 | ||||||
| 2013-02-24 | $2.33M 10-Q · filed 2014-03-28 | $4.44M derived: sum of 2 quarters · filed 2014-03-28 | $6.64M 10-Q · filed 2014-03-28 | $9.13M derived: sum of 4 quarters · filed 2014-08-01 | ||||||
| 2012-11-25 | $2.11M 10-Q · filed 2014-01-03 | $4.32M 10-Q · filed 2014-01-03 | $6.80M derived: sum of 3 quarters · filed 2014-08-01 | $9.27M derived: sum of 4 quarters · filed 2014-08-01 | ||||||
| 2012-08-26 | $2.20M 10-Q · filed 2013-09-26 | $4.69M derived: sum of 2 quarters · filed 2014-08-01 | $7.16M derived: sum of 3 quarters · filed 2014-08-01 | $9.50M derived: sum of 4 quarters · filed 2014-08-01 | ||||||
| 2012-05-27 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $4.96M derived: sum of 2 quarters · filed 2014-08-01 | $7.29M derived: sum of 3 quarters · filed 2014-08-01 | $9.63M 10-K · filed 2014-08-01 | ||||||
| 2012-02-26 | $2.47M 10-Q · filed 2013-04-04 | $4.81M derived: sum of 2 quarters · filed 2013-04-04 | $7.14M 10-Q · filed 2013-04-04 | $9.66M derived: sum of 4 quarters · filed 2013-08-07 | ||||||
| 2011-11-27 | $2.34M 10-Q · filed 2013-01-04 | $4.67M 10-Q · filed 2013-01-04 | $7.18M derived: sum of 3 quarters · filed 2013-08-07 | $9.46M derived: sum of 4 quarters · filed 2013-08-07 | ||||||
| 2011-08-28 | $2.33M 10-Q/A · filed 2013-01-02 | $4.85M derived: sum of 2 quarters · filed 2013-08-07 | $7.12M derived: sum of 3 quarters · filed 2013-08-07 | $9.38M derived: sum of 4 quarters · filed 2013-08-07 | ||||||
| 2011-05-29 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $4.79M derived: sum of 2 quarters · filed 2013-08-07 | $7.04M derived: sum of 3 quarters · filed 2013-08-07 | $9.28M 10-K · filed 2013-08-07 | ||||||
| 2011-02-27 | $2.27M 10-Q · filed 2012-03-28 | $4.53M derived: sum of 2 quarters · filed 2012-03-28 | $6.76M 10-Q · filed 2012-03-28 | |||||||
| 2010-11-28 | $2.25M 10-Q · filed 2012-01-05 | $4.49M 10-Q · filed 2012-01-05 | ||||||||
| 2010-08-29 | $2.23M 10-Q · filed 2011-10-05 | |||||||||
| 2010-05-30 | $4.36M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |